Role of Khadir and Chirabilva in treatment of Diabetes

A Comparative clinical study of Chirabilva (Holoptelea integrifolia Planch) and Khadir (Acacia catectu L.f.) on Prameha W.S.R. to Diabetes Mellitus - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/083968

Enrollment

Registered

2025-04-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age of patient should be lie between 30-65 years Both obese and non-obese patients FBS level from 120 to 250 mg/dl PPBS level from 180-350mg/dl HbA1C is 5.7to 7.0

Exclusion criteria

Exclusion criteria: Patients have other complications of diabetes like DKA, HTN, UTI will be excluded. Patients having insulin dependent diabetes mellitus and receiving insulin. . Excessive blood glucose levels, FBS exceeding 250mg/dl, PPBS more than 350mg/dl. Emergency cases in DM. Garbhini and Sutika.

Design outcomes

Primary

Measure	Time frame
changes in symptoms and elevated blood glucose levelTimepoint: changes in symptoms and elevated blood glucose level on 9th week	—

Secondary

Measure	Time frame
assessment of changes in clinical parameter after 2 weeksTimepoint: 1st follow up on 3rd week 2nd follow upon 5th week 3rd follow up at 7th week after treatment 9th week	—

Countries

India

Contacts

Public ContactDr Shiv Kumar Mishra

Govt Auto Dhanwantri Ayurved Medical College

dr.shivkumarmishra88@gmail.com8871516064

Outcome results